186 related articles for article (PubMed ID: 17451681)
21. Loss of human Scribble cooperates with H-Ras to promote cell invasion through deregulation of MAPK signalling.
Dow LE; Elsum IA; King CL; Kinross KM; Richardson HE; Humbert PO
Oncogene; 2008 Oct; 27(46):5988-6001. PubMed ID: 18641685
[TBL] [Abstract][Full Text] [Related]
22. MDA-9/Syntenin-Slug transcriptional complex promote epithelial-mesenchymal transition and invasion/metastasis in lung adenocarcinoma.
Wang LK; Pan SH; Chang YL; Hung PF; Kao SH; Wang WL; Lin CW; Yang SC; Liang CH; Wu CT; Hsiao TH; Hong TM; Yang PC
Oncotarget; 2016 Jan; 7(1):386-401. PubMed ID: 26561205
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1.
Ramer R; Hinz B
J Natl Cancer Inst; 2008 Jan; 100(1):59-69. PubMed ID: 18159069
[TBL] [Abstract][Full Text] [Related]
24. BAG3 regulates motility and adhesion of epithelial cancer cells.
Iwasaki M; Homma S; Hishiya A; Dolezal SJ; Reed JC; Takayama S
Cancer Res; 2007 Nov; 67(21):10252-9. PubMed ID: 17974966
[TBL] [Abstract][Full Text] [Related]
25. Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-kappaB.
Boukerche H; Aissaoui H; Prévost C; Hirbec H; Das SK; Su ZZ; Sarkar D; Fisher PB
Oncogene; 2010 May; 29(21):3054-66. PubMed ID: 20228839
[TBL] [Abstract][Full Text] [Related]
26. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
27. Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates.
Yamazaki D; Kurisu S; Takenawa T
Oncogene; 2009 Apr; 28(13):1570-83. PubMed ID: 19234490
[TBL] [Abstract][Full Text] [Related]
28. Up-regulation of Rho/ROCK signaling in sarcoma cells drives invasion and increased generation of protrusive forces.
Rösel D; Brábek J; Tolde O; Mierke CT; Zitterbart DP; Raupach C; Bicanová K; Kollmannsberger P; Panková D; Vesely P; Folk P; Fabry B
Mol Cancer Res; 2008 Sep; 6(9):1410-20. PubMed ID: 18819929
[TBL] [Abstract][Full Text] [Related]
29. Syntenin-1 is a promoter and prognostic marker of head and neck squamous cell carcinoma invasion and metastasis.
Cui L; Cheng S; Liu X; Messadi D; Yang Y; Hu S
Oncotarget; 2016 Dec; 7(50):82634-82647. PubMed ID: 27811365
[TBL] [Abstract][Full Text] [Related]
30. Structural insights into the PIP2 recognition by syntenin-1 PDZ domain.
Sugi T; Oyama T; Morikawa K; Jingami H
Biochem Biophys Res Commun; 2008 Feb; 366(2):373-8. PubMed ID: 18062914
[TBL] [Abstract][Full Text] [Related]
31. NG2-mediated Rho activation promotes amoeboid invasiveness of cancer cells.
Paňková D; Jobe N; Kratochvílová M; Buccione R; Brábek J; Rösel D
Eur J Cell Biol; 2012; 91(11-12):969-77. PubMed ID: 22699001
[TBL] [Abstract][Full Text] [Related]
32. Syntenin increases the invasiveness of small cell lung cancer cells by activating p38, AKT, focal adhesion kinase and SP1.
Kim WY; Jang JY; Jeon YK; Chung DH; Kim YG; Kim CW
Exp Mol Med; 2014 Apr; 46(4):e90. PubMed ID: 24722482
[TBL] [Abstract][Full Text] [Related]
33. Syntenin: PDZ Protein Regulating Signaling Pathways and Cellular Functions.
Shimada T; Yasuda S; Sugiura H; Yamagata K
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31454940
[TBL] [Abstract][Full Text] [Related]
34. The ins and outs of syntenin, a multifunctional intracellular adaptor protein.
Beekman JM; Coffer PJ
J Cell Sci; 2008 May; 121(Pt 9):1349-55. PubMed ID: 18434645
[TBL] [Abstract][Full Text] [Related]
35. Syntenin-targeted peptide blocker inhibits progression of cancer cells.
Liu J; Qu J; Zhou W; Huang Y; Jia L; Huang X; Qian Z; Xia J; Yu Y
Eur J Med Chem; 2018 Jun; 154():354-366. PubMed ID: 29857221
[TBL] [Abstract][Full Text] [Related]
36. A laminin-collagen complex drives human epidermal carcinogenesis through phosphoinositol-3-kinase activation.
Waterman EA; Sakai N; Nguyen NT; Horst BA; Veitch DP; Dey CN; Ortiz-Urda S; Khavari PA; Marinkovich MP
Cancer Res; 2007 May; 67(9):4264-70. PubMed ID: 17483338
[TBL] [Abstract][Full Text] [Related]
37. Estrogen and progestin regulate metastasis through the PI3K/AKT pathway in human ovarian cancer.
Hua K; Feng W; Cao Q; Zhou X; Lu X; Feng Y
Int J Oncol; 2008 Nov; 33(5):959-67. PubMed ID: 18949358
[TBL] [Abstract][Full Text] [Related]
38. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
[TBL] [Abstract][Full Text] [Related]
39. Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion.
Moon A; Yong HY; Song JI; Cukovic D; Salagrama S; Kaplan D; Putt D; Kim H; Dombkowski A; Kim HR
Mol Cancer Res; 2008 Oct; 6(10):1544-53. PubMed ID: 18922970
[TBL] [Abstract][Full Text] [Related]
40. Positive regulation of migration and invasion by vasodilator-stimulated phosphoprotein via Rac1 pathway in human breast cancer cells.
Han G; Fan B; Zhang Y; Zhou X; Wang Y; Dong H; Wei Y; Sun S; Hu M; Zhang J; Wei L
Oncol Rep; 2008 Oct; 20(4):929-39. PubMed ID: 18813837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
